About PHC Holdings
PHC Holdings is a publicly listed company based in Minato (Japan) founded in 1969, and was acquired by KKR in September 2013. Devices and services for life science research are provided. PHC Holdings has raised $182.35 million across 1 funding round from investors including KKR and L Catterton. The company has 9,040 employees. PHC Holdings has completed 3 acquisitions, including Fujifilm, MM France and SciMed. Its chief executive, as recorded, is Hidehito Kotani. Its website phchd.com draws about 268 thousand monthly visits. PHC Holdings offers products and services including Glucose Monitoring Systems, Clinical Testing Services, and Electronic Medical Record Systems. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Diversified. Its legal entity is PHC.
Company details
PHC Holdings was founded in 1969 and is headquartered in Minato City, Japan. Devices and services for life science research are supplied by the company within the healthcare and life sciences sector. Test analysis devices, healthcare IT solutions, and instruments for the life sciences industry are developed. Drug delivery solutions and medical record systems are also provided to support research and operational needs.
- Headquarters Minato, Japan
- Employees 9,040
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website phchd.com/global
- Social LinkedIn X Facebook
- Acquired by KKR (Sep 2013)
- Legal Name Phc Holdings Corp.
- Annual Revenue$2.28 B (USD)0.78as on Mar 31, 2026
- Net Profit$3.08 M (USD)-95.31as on Mar 31, 2026
- EBITDA$299.13 M (USD)-4.18as on Mar 31, 2026
- Total Equity Funding$182.35M (USD)
in 1 rounds
- Latest Funding Round$182.35M (USD), Series D
Mar 2021
- InvestorsKKR
& 1 more
- Employee Count9,040
- Investments & AcquisitionsFujifilm
& 2 more
- Acquired byKKR
(Sep 2013)
Products & Services of PHC Holdings
PHC Holdings offers a comprehensive portfolio of products and services, including Glucose Monitoring Systems, Clinical Testing Services, and Electronic Medical Record Systems.
Devices for monitoring blood glucose levels in patients
Services supporting illness prevention and treatment through testing
Systems for managing patient records and prescriptions
Funding Insights of PHC Holdings
PHC Holdings has successfully raised a total of $182.35M through 1 strategic funding round. The most recent funding activity was a Series D round of $182.35 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $182.35M
- Total Rounds 1
- Last Round Series D β $182.35M
- First Round $182.35M
(Mar 2021)
- Investors Count 1
All 1 funding rounds of PHC Holdings with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | $182.35M | Series D | β | L Catterton | β |
2 investors in total: 2 institutional.
Investors in PHC Holdings
PHC Holdings has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include KKR and L Catterton.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
L Catterton is recognized as a leading consumer-focused private equity group. | lcatterton.com | Greenwich, United States | ||
Multiple sectors are invested in by this private equity firm. | 1976 | kkr.com | New York, United States |
Investor details for PHC Holdings
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PHC Holdings
21 people are tracked at PHC Holdings (8 in leadership, 13 in team); the tracked headcount is 9,040.
| Name | Role | Group |
|---|---|---|
Hidehito Kotani | Co-CEO | Leadership |
Shoji Miyazaki | Co-CEO | Leadership |
Frank Gonzales | Director Of Sales, Trans Atlantic Region | Leadership |
Andy Garrison | Director Of Sales - East | Leadership |
Nancy Larsen | Vice President, Head Of Operations | Leadership |
Joe Laporte | Chief Innovation Officer | Leadership |
Lynn Moore | Vice President, Sales North America | Leadership |
Anthony S. | Marketing Director | Leadership |
Barbara Ruelas | CRM And Sales Automation Specialist | Team |
Lisa Holmquist | Sales Operations Manager | Team |
Jim Santiago | Area Sales Manager | Team |
David Cassanelli | Area Manager | Team |
Federico Venegas | Territory Manager | Team |
Davidmichael Dawson | Inside Sales Associate | Team |
Kristin Crisolo | Area Sales Manager | Team |
Michael Higgins | Territory Manager | Team |
Michael Smith | Territory Sales Manager | Team |
Jane Bowman Ford | Area Manager | Team |
Lisa Lambert-Davis | Area Sales Manager | Team |
Steven Hubbard | Business Process & Systems Improvement Principal | Team |
1 more people are available in the full profile.
Complete people profiles for PHC Holdings
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of PHC Holdings
PHC Holdings is a publicly listed company on the TSE with ticker symbol 6523 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date14 Oct 2021
- Listed onTSE: 6523
- Listed entityPHC Holdings Corp.
- Exchange sectorHealth technology
- ISINJP3801300009
- Share price1,362.00 JPY (-0.07% on the day) · 2026-10-14
- Market capitalisation173,547,485,657.00 JPY
- Price to earnings18.9
- EPS (diluted, trailing year)72.21 JPY
- Dividend yield2.65%
- Volume (last session)1,464,900
Financials of PHC Holdings
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 364.40B JPY | 492.0M JPY | 47.71B JPY |
| 2024 | 361.59B JPY | 10.48B JPY | 49.79B JPY |
| 2023 | 353.90B JPY | -12.89B JPY | 36.24B JPY |
| 2022 | 356.43B JPY | -3.22B JPY | 57.49B JPY |
| 2021 | 340.45B JPY | -8.46B JPY | 54.11B JPY |
Detailed financial statements for PHC Holdings
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PHC Holdings
PHC Holdings has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Fujifilm, MM France and SciMed.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Multiple sectors are invested in by the venture capital firm. | fujifilm.com | Minato, Japan | 1934 | Oct 2023 | β’β’β’β’ | |
Medical consumables, stainless steel, and instruments are manufactured and supplied. | mm-france.fr | Brignais, France | 1987 | Sep 2022 | β’β’β’β’ | |
Provider of products and services for biomedical, education, healthcare, industrial laboratory and life sciences sector | scimed.com.sg | Singapore | 1992 | Jul 2020 | β’β’β’β’ |
Complete acquisition details for PHC Holdings
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of PHC Holdings
7 dated milestones of PHC Holdings across 54 years, from founding to its latest funding, stage changes and deals.
Web traffic of PHC Holdings
The website of PHC Holdings (phchd.com) receives about 268.1K visits a month and ranks #188,013 among all websites worldwide, #6,040 in Biotechnology and Pharmaceuticals.
- Monthly visits268.1K
▲ 13.8% vs previous month
- Unique visitors133.4K
per month
- Global rank#188,013
among all websites
- Category rank#6,040
Health · Biotechnology and Pharmaceuticals
- Bounce rate52%
- Pages per visit2.3
- Average visit1 min 46 sec
- DevicesDesktop 52% Β· Mobile 48%
Websites whose visitors overlap most with PHC Holdings. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
medicalcenterjp.com | medicalcenterjp.com | 100% | #1,486,603 | β | |
credo-m.co.jp | credo-m.co.jp | 98% | #581,762 | β | |
clinicstation.jp | clinicstation.jp | 98% | #1,553,638 | β | |
wakenyaku.co.jp | wakenyaku.co.jp | 95% | #545,917 | β | |
| clius.jp | 94% | #19,716 | View details | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for PHC Holdings
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Phc Holdings
Complete news archive for PHC Holdings
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PHC Holdings
PHC Holdings was founded in 1969 and raised its 1st funding round 52 years after it was founded.
PHC Holdings is headquartered in Minato, Japan. It is registered at Minato, Tokyo, Japan.
Hidehito Kotani is the CEO of PHC Holdings, as recorded in our data.
PHC Holdings is a funded company, having raised a total of $182.35M across 1 funding round to date. The company's 1st funding round was a Series D of $182.35M, raised on Mar 2021.
PHC Holdings has 9,040 employees.
Annual revenue of PHC Holdings is $2.28B as on Mar 31, 2026.
PHC Holdings was founded in 1969 and is headquartered in Minato City, Japan. Devices and services for life science research are supplied by the company within the healthcare and life sciences sector. Test analysis devices, healthcare IT solutions, and instruments for the life sciences industry are developed. Drug delivery solutions and medical record systems are also provided to support research and operational needs.
PHC Holdings offers Glucose Monitoring Systems, Clinical Testing Services, and Electronic Medical Record Systems.
Yes, PHC Holdings is publicly traded on TSE under the ticker symbol 6523.
PHC Holdings has 2 investors. Key investors include KKR, and L Catterton.
PHC Holdings operates through Phc.

